<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Translocation t(6:9)(p23;q34), resulting in a dek-can gene fusion, is a recurrent chromosomal abnormality mainly associated with specific subtypes of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with this type of chromosomal change are usually young and their prognosis is poor </plain></SENT>
<SENT sid="2" pm="."><plain>The role of fusion protein generated from dek-can chimaeric transcript on the leukaemogenesis oft(6;9) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is as yet unknown </plain></SENT>
<SENT sid="3" pm="."><plain>We have established the first permanent cell line (FKH-1) with t(6;9). derived from the peripheral blood of a patient with t(6:9) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> transformed from Philadelphia chromosome (Ph1)-negative <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:mp ids='MP_0005481'>CML</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>The FKH-1 expressed myelomonocytic markers and dek-can chimaeric transcript </plain></SENT>
<SENT sid="5" pm="."><plain>In the presence of 10 ng/ml recombinant human granulocyte colony-stimulating factor (G-CSF), the cells doubled every 54 h and showed multilineage myeloid differentiation, resulting in heterogenous <z:mp ids='MP_0000002'>morphologies</z:mp> such as macrophages, basophils, eosinophils and neutrophils </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, this cell line may be derived from a pluripotent myeloid stem cell and should be a useful tool for biomolecular studies on the pathogenesis of t(6;9) <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> which have rarely been investigated because of the lack of continuously proliferating cells </plain></SENT>
</text></document>